Rivaroxaban is Comparable to Warfarin in Prevention of Thromboembolism in Patients with Non-Valvular Atrial Fibrillation with Valvular Heart Disease: A Systematic Review and Meta-analysis
暂无分享,去创建一个
P. Sud | H. Changezi | M. Akanbi | G. Adhikari | N. Baral | R. Rauniyar | B. Abdelazeem | P. Savarapu | S. Isa | M. R. Khan | A. Kunadi | B. Malik | H. Khan | A. Katel | A. Khan | M. Ahmad | A. Khan